Rivaroxaban Completed Phase 3 Trials for Deep Venous Thrombosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02486445Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study